Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Katayoon Goodarzi, M.D.

Co-Author

This page shows the publications co-authored by Katayoon Goodarzi and Hanny Al-Samkari.
Connection Strength

3.125
  1. Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case Report. Ann Intern Med. 2021 11; 174(11):1632-1633.
    View in: PubMed
    Score: 0.959
  2. An Eltrombopag Red (Plasma) Alert. Acta Haematol. 2021; 144(2):227-228.
    View in: PubMed
    Score: 0.885
  3. Thrombopoietin level predicts response to treatment with romiplostim in chemotherapy-induced thrombocytopenia. Am J Hematol. 2021 12 01; 96(12):1563-1568.
    View in: PubMed
    Score: 0.239
  4. A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies. Haematologica. 2021 04 01; 106(4):1148-1157.
    View in: PubMed
    Score: 0.232
  5. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020 07 23; 136(4):489-500.
    View in: PubMed
    Score: 0.221
  6. A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia. Blood Adv. 2020 01 14; 4(1):9-18.
    View in: PubMed
    Score: 0.213
  7. Romiplostim for the management of perioperative thrombocytopenia. Br J Haematol. 2018 07; 182(1):106-113.
    View in: PubMed
    Score: 0.190
  8. The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors. Haematologica. 2018 04; 103(4):e169-e172.
    View in: PubMed
    Score: 0.185
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.